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Objective 
Glucose-insulin pharmacokinetic-pharmacodynamic (PK-PD) 
models can be used for improved glycemic control of critically ill 
patients.  
A key component of glucose-insulin PK-PD models is pancreatic 
insulin secretion.  
There is limited data in the literature quantifying insulin 
secretion in critically ill patients at physiologic levels. 
Using prospectively collected data, this study creates a model 
of pancreatic insulin secretion in critically ill patients to improve 
glucose-insulin system modeling. 
Subjects 
19 patients from the Christchurch Hospital ICU  
enrolled in a prospective clinical trial studying sepsis. 
Patients were included in the study if they met  
all of the following criteria: 
 Age ≥ 16 years. 
 Expected survival ≥ 72 hours. 
 Expected ICU length of stay ≥ 48 hours. 
 Entry to the SPRINT TGC protocol. 
 Suspected sepsis or SIRS score ≥ 3. 
No diagnosed Type I diabetic patients were included. 
Samples 
Each patient had two sets of arterial blood samples taken, where 
each set consisted of 4 separate samples.  
 The first set of samples was taken at the 
commencement of the SPRINT TGC protocol.  
 The second set was taken when the patient 
consistently met less than 2 of the SIRS criteria 
Insulin and C-peptide concentrations were determined using 
immunometric assays. 
Blood glucose levels were measured with a bedside glucometer 
at t = 0 and t = 60 mins as per normal clinical practise. 
N 19 
Age (years) 68 [57-75] 
Gender (M/F) 10/9 
APACHE II score 22.0 [18.3-26.8] 
Confirmed sepsis 79% 
Hospital mortality (L/D) 13/6 
Diagnosed T2DM 3 
Methods 
Pancreatic insulin secretion rates were deconvolved from C-
peptide data using the model and population constants of van 
Cauter et al.  
Data from literature suggested a maximum secretion rate of 
16U/hr.  
A minimum rate of 1U/hr was also adopted. 
Model fitting was performed by minimising the sum of the 
geometric means of the squared deviations in each dimension 
Results 
The best model for insulin secretion, in terms of both fit to data and 
simplicity is the 1-dimensional model based on blood glucose (BG) 
concentration alone.  
The clear separation between non-diabetic (ND) and T2DM patients 
suggests two separate models for insulin secretion (Uen): 
 
ND:    Uen = 893xBG – 2996    constrained to [1000-16000] mU/hr 
T2DM:    Uen = 296xBG – 1644    constrained to [1000-16000] mU/hr 
 
Model fits achieve coefficients of variation of R2 = 0.61 and R2 = 0.69 for ND 
and T2DM, respectively. 
The model slopes compare well with published data for healthy and diabetic 
individuals 
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